CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
June 22, 2021—Epredia and Aiforia announced they have entered into a commercial distribution agreement for Aiforia’s portfolio of preclinical and clinical pathology tools. Aiforia aims to equip pathologists with AI-powered, secure, and scalable cloud-based software for high-precision image analysis. Its solutions aim to enhance the speed and accuracy of pharmaceutical drug development and cancer diagnostics.
The terms of the agreement include segment exclusivity for distribution in Japan, Germany, U.K., Italy, Spain, Sweden, Norway, Denmark, Iceland, France, and the United States. The products will be available as part of Epredia’s digital pathology portfolio, which includes the CE-marked 3DHistech P1000 WSI scanner.
Pages: 1 2